• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co announces the successful €18m Private Placement of Nicox

Nicox tombstone

Bryan Garnier & Co advises GeNeuro on its Euronext IPO, raising €33 million, acting as Global Coordinator & Joint Bookrunner

GeNeuro tombstone

Capital Raise Florealis

Florealis_tombstone_feb16

Bryan, Garnier & Co announces the successful €25m Placement of Erytech

Erytech tombstone

Bryan Garnier & Co advises DBV Technologies on its follow-on offering, raising $281.5m in July 2015, acting as financial advisor

DBV Technologies tombstone

Bryan, Garnier & Co announces the successful $100m Nasdaq IPO of Celyad.

Celyad 2015 tombstone

Bryan, Garnier & Co announces that the total proceeds of Galapagos IPO on Nasdaq, the largest Nasdaq IPO of a European biotech, have been raised to $317m following the full exercise of over-allotment option.

Galapagos tombstone

Bryan, Garnier & Co announces the successful follow-on offering of £20m for Advanced Oncotherapy plc

Advanced Oncotherapy tombstone

Bryan, Garnier & Co acts as Placement Agent for Nicox €27m Private Placement (PIPE)

Nicox 2015 tombstone

Bryan, Garnier & Co acts as Placement Agent for Cardio3 BioScience’s €32m Capital Raise

Cardio3 tombstone

Bryan, Garnier & Co announces the successful IPO of Bone Therapeutics.

Bone Therapeutics 2015 tombstone

Bryan, Garnier & Co announces the IPO of Quantum Pharma on London AIM

Quantum Pharma tombstone
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 15

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }